BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30621300)

  • 21. Aerosolized protein delivery in asthma: gamma camera analysis of regional deposition and perfusion.
    Sangwan S; Agosti JM; Bauer LA; Otulana BA; Morishige RJ; Cipolla DC; Blanchard JD; Smaldone GC
    J Aerosol Med; 2001; 14(2):185-95. PubMed ID: 11681650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Size distribution of chromate paint aerosol generated in a bench-scale spray booth.
    Sabty-Daily RA; Hinds WC; Froines JR
    Ann Occup Hyg; 2005 Jan; 49(1):33-45. PubMed ID: 15596421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerosol generation by metered-dose inhalers containing dimethyl ether/propane inverse microemulsions.
    Sommerville ML; Hickey AJ
    AAPS PharmSciTech; 2003 Nov; 4(4):E58. PubMed ID: 15198553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery.
    Beck-Broichsitter M; Oesterheld N; Knuedeler MC; Seeger W; Schmehl T
    Int J Pharm; 2014 Jan; 461(1-2):34-7. PubMed ID: 24291081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A system for the production and delivery of monodisperse salbutamol aerosols to the lungs.
    Biddiscombe MF; Usmani OS; Barnes PJ
    Int J Pharm; 2003 Mar; 254(2):243-53. PubMed ID: 12623200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous nebulization therapy for asthma with aerosols of beta2 agonists.
    Raabe OG; Wong TM; Wong GB; Roxburgh JW; Piper SD; Lee JI
    Ann Allergy Asthma Immunol; 1998 Jun; 80(6):499-508. PubMed ID: 9647274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of nebulizer type with different pediatric aerosol masks on drug deposition in a model of a spontaneously breathing small child.
    Lin HL; Wan GH; Chen YH; Fink JB; Liu WQ; Liu KY
    Respir Care; 2012 Nov; 57(11):1894-900. PubMed ID: 22418694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery.
    O'Riordan TG; Palmer LB; Smaldone GC
    Am J Respir Crit Care Med; 1994 Jan; 149(1):214-9. PubMed ID: 8111585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reconciliation of Cascade Impaction during Wet Nebulization.
    Solomita M; Smaldone GC
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):11-8. PubMed ID: 19392585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Particle size study of nine metered dose inhalers, and their deposition probabilities in the airways.
    Bouchikhi A; Becquemin MH; Bignon J; Roy M; Teillac A
    Eur Respir J; 1988 Jun; 1(6):547-52. PubMed ID: 3169224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of tubing deposition, breathing pattern, and temperature on aerosol mass distribution measured by cascade impactor.
    Gurses BK; Smaldone GC
    J Aerosol Med; 2003; 16(4):387-94. PubMed ID: 14977429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Size distribution and speciation of chromium in paint spray aerosol at an aerospace facility.
    Sabty-Daily RA; Harris PA; Hinds WC; Froines JR
    Ann Occup Hyg; 2005 Jan; 49(1):47-59. PubMed ID: 15591325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns.
    Berg EB; Picard RJ
    Respir Care; 2009 Dec; 54(12):1671-8. PubMed ID: 19961633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing the size distribution of aerosols from jet nebulisers.
    Clay MM; Pavia D; Newman SP; Clarke SW
    Thorax; 1983 Oct; 38(10):755-9. PubMed ID: 6648854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The physical properties of a jet-nebulizer and their relevance for the histamine provocation test.
    Sterk PJ; Plomp A; Crobach MJ; van de Vate JF; Quanjer PH
    Bull Eur Physiopathol Respir; 1983; 19(1):27-36. PubMed ID: 6850144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of nose-only aerosol inhalation chamber and comparison of experimental results with mathematical simulation of aerosol deposition in mouse lungs.
    Nadithe V; Rahamatalla M; Finlay WH; Mercer JR; Samuel J
    J Pharm Sci; 2003 May; 92(5):1066-76. PubMed ID: 12712427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of new-generation high-power electronic nicotine delivery system as thermal aerosol generation device for inhaled bronchodilators.
    Pourchez J; de Oliveira F; Perinel-Ragey S; Basset T; Vergnon JM; Prévôt N
    Int J Pharm; 2017 Feb; 518(1-2):264-269. PubMed ID: 28062365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nebulizer delivery of tobramycin to the lower respiratory tract.
    Weber A; Smith A; Williams-Warren J; Ramsey B; Covert DS
    Pediatr Pulmonol; 1994 May; 17(5):331-9. PubMed ID: 8058428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selected parameters affecting characterization of nebulized aqueous solutions by inertial impaction and comparison with phase-Doppler analysis.
    Dunbar CA; Hickey AJ
    Eur J Pharm Biopharm; 1999 Sep; 48(2):171-7. PubMed ID: 10469935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a Nebulizer Holding Chamber on Aerosol Delivery.
    Sarhan RM; Elberry AA; Abdelwahab NS; Rabea H; Salem MN; Abdelrahim ME
    Respir Care; 2018 Sep; 63(9):1125-1131. PubMed ID: 29789412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.